Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam · Delayed Price · Currency is VND 48,200
-800 (-1.63%)
At close: Jul 24, 2026
HOSE:DBD Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,872,421 | 1,865,380 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 |
Revenue Growth | 4.91% | 7.98% | 4.59% | 6.24% | -0.24% | 23.99% |
Gross Profit Gross Profit Growth | 860,097 | 884,379 | 832,573 | 798,520 | 767,652 | 622,566 |
Operating Income Operating Income Growth | 319,791 | 326,276 | 305,592 | 296,982 | 273,339 | 217,129 |
Net Income Net Income Growth | 250,311 | 251,022 | 236,656 | 231,387 | 209,457 | 162,646 |
Earnings Per Share EPS Growth | 2649.09 | 2673.96 | 2529.63 | 2473.00 | 2238.88 | 1738.52 |
EPS Growth | -1.07% | 5.71% | 2.29% | 10.46% | 28.78% | 17.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 570,773 | 611,985 | 438,620 | 309,032 | 276,953 | 208,641 |
Total Debt Total Debt Growth | 269,033 | 175,215 | 63,914 | 79,267 | 76,000 | 97,029 |
Net Cash (Debt) Net Cash Growth | 301,740 | 436,770 | 374,706 | 229,765 | 200,953 | 111,612 |
Net Cash Growth | -16.70% | 16.56% | 63.08% | 14.34% | 80.05% | -6.61% |
Net Cash Per Share Net Cash Per Share Growth | 3193.38 | 4652.59 | 4005.25 | 2455.96 | 2147.98 | 1193.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 477,388 | 615,187 | 264,730 | 282,356 | 165,012 | 117,568 |
Capital Expenditures CapEx Growth | -394,505 | -408,573 | -148,745 | -133,694 | -82,828 | -54,636 |
Free Cash Flow Free Cash Flow Growth | 82,883 | 206,614 | 115,985 | 148,663 | 82,184 | 62,932 |
Free Cash Flow Growth | -43.41% | 78.14% | -21.98% | 80.89% | 30.59% | -58.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 45.93% | 47.41% | 48.19% | 48.34% | 49.37% | 39.95% |
Operating Margin | 17.08% | 17.49% | 17.69% | 17.98% | 17.58% | 13.93% |
Pretax Margin | 18.46% | 18.55% | 18.82% | 19.38% | 19.20% | 14.91% |
Profit Margin | 13.37% | 13.46% | 13.70% | 14.01% | 13.47% | 10.44% |
FCF Margin | 4.43% | 11.08% | 6.71% | 9.00% | 5.29% | 4.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2000.000 | - | 2000.000 | - | 1600.000 |
Dividend Per Share Growth | - | - | - | - | - |
Dividend Yield | 4.08% | - | 3.60% | - | 5.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.19 | 18.37 | 22.77 | 17.53 | 14.10 | 18.37 |
Forward PE | - | 18.50 | 19.36 | 13.51 | 12.33 | 12.11 |
P/FCF Ratio | 54.95 | 22.32 | 46.46 | 27.29 | 35.93 | 47.48 |
PS Ratio | 2.43 | 2.47 | 3.12 | 2.46 | 1.90 | 1.92 |